Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06715241 |
| Title | A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II of RELATLIMAB and NIVOLUMAB VS NIVOLUMAB ALONE in LOCALLY ADVANCED CERVICAL CANCERS (COLIBRI-2) |
| Acronym | COLIBRI-2 |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | ARCAGY/ GINECO GROUP |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | FRA |